Dr. Annie Lent opens up about her winding path into medicine, training at National Jewish, and 15+ years in private practice. She recounts six intense weeks that pushed her to act: workplace misfires using legacy epinephrine pens, a mother’s near miss during a peanut reaction, and a fatal bee-sting allergy the patient couldn’t afford to treat. Annie explains why current auto-injectors are clunky, costly, and not kid-friendly, and why intranasal epinephrine isn’t the answer in a real anaphylaxis.
We get the founder story behind Albeta (say it out loud: “all better”)—a dry-needle emergency delivery system concept that could be used for epinephrine, naloxone, and more. Annie shares lessons in resilience, fundraising, assembling the right team, and balancing an 80-hour “day job” with a startup “night job.” She also reflects on purpose, missions to Nicaragua, and the joy of patient connection.
Highlights
-
From Boston College philosophy major to allergy/immunology specialist
-
The catalyst: three back-to-back safety/affordability realities around epinephrine
-
Why intranasal isn’t practical during anaphylaxis (kids, congestion, vasodilation)
-
Building Albeta: patents pending (US & EU), non-working prototype, raising next round
-
The team: Cambridge Design Partnership (UK), Cooley (corporate), Billy Smith (patents), Healthcare Deciphered (consulting)
-
Habits that help: structured evenings, high-volume outreach, relentless follow-through
-
Purpose and perspective from global medical missions
👉 Are you a medical professional with a story, insight, or strategy to share about career, personal, or financial success? We’d love to hear from you! Apply to be a guest on our podcast here: https://stellarsuccesspodcast.com/guest #motivation #success #health #business #leadership #education #career #podcast #inspiration #wellness
No comments yet. Be the first to say something!